ECSP993282A - 4 - ARYLOXINDOLES - Google Patents

4 - ARYLOXINDOLES

Info

Publication number
ECSP993282A
ECSP993282A ECSP993282A ECSP993282A EC SP993282 A ECSP993282 A EC SP993282A EC SP993282 A ECSP993282 A EC SP993282A EC SP993282 A ECSP993282 A EC SP993282A
Authority
EC
Ecuador
Prior art keywords
compounds
pharmaceutically acceptable
formula
treatment
acceptable salts
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Kin Chun Luk
Yi Chen
Corbett Wendy Lea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993282 priority Critical patent/ECSP993282A/en
Publication of ECSP993282A publication Critical patent/ECSP993282A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Este invento se refiere alkenyl-4-y 4-alkynyl oxindoles tener la formulaand las sales farmacéuticamente aceptable del mismo, donde R1, R2, R3, a, b, y X son definidos aquí. Estos compuestos inhiben quinasas dependientes de ciclina (CDKs), en particular CDK2. Estos compuestos y sus sales farmacéuticamente aceptable, y dijo prodrugs de compuestos, son anti-proliferativa agentes útiles en el tratamiento o control de proliferación de células de los trastornos, en particular el cáncer, más en particular, el tratamiento o control de los tumores de mama y colon. Reveló también son composiciones farmacéuticas que contienen los compuestos de fórmula I y II, así como intermediarios útiles en la preparación de los compuestos de fórmula I y II.This invention relates to alkenyl-4-and 4-alkynyl oxindoles having the formuland the pharmaceutically acceptable salts thereof, where R1, R2, R3, a, b, and X are defined herein. These compounds inhibit cyclin-dependent kinases (CDKs), in particular CDK2. These compounds and their pharmaceutically acceptable salts, and said prodrugs of compounds, are anti-proliferative agents useful in the treatment or control of cell proliferation of disorders, in particular cancer, more particularly, the treatment or control of tumors of breast and colon. It also disclosed are pharmaceutical compositions containing the compounds of formula I and II, as well as intermediates useful in the preparation of the compounds of formula I and II.

ECSP993282 1999-12-17 1999-12-17 4 - ARYLOXINDOLES ECSP993282A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993282 ECSP993282A (en) 1999-12-17 1999-12-17 4 - ARYLOXINDOLES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993282 ECSP993282A (en) 1999-12-17 1999-12-17 4 - ARYLOXINDOLES

Publications (1)

Publication Number Publication Date
ECSP993282A true ECSP993282A (en) 2000-07-21

Family

ID=42044272

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993282 ECSP993282A (en) 1999-12-17 1999-12-17 4 - ARYLOXINDOLES

Country Status (1)

Country Link
EC (1) ECSP993282A (en)

Similar Documents

Publication Publication Date Title
CY1108408T1 (en) DIAZEPINOIDOLINE PRODUCTS AS MOVING SUSPENSIONS
PA8537401A1 (en) DIAMINOTIAZOLES
UY29458A1 (en) REPLACED HETEROCICLES AND USES OF THE SAME
ECSP034642A (en) DERIVATIVES OF TETRALONA AS ANTITUMOR AGENTS
AR024847A1 (en) 4-ALQUENIL AND 4-ALQUINIL OXINDOLS, PHARMACEUTICAL COMPOSITION AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT.
PA8609701A1 (en) [1,8] NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA
ECSP055640A (en) PIRAZOL COMPOSITIONS USEFUL AS INHIBITORS OF GSK-3
PA8582601A1 (en) HETEROCICLIC PIPERAZINAS REPLACED FOR THE TREATMENT OF CHICHOPHRENIA
UY27350A1 (en) AZAINDOLS
GT200300289A (en) PIRROLOPIRIMIDINE DERIVATIVES
AR028810A1 (en) DERIVATIVES OF ARILPIPERAZINIL-CICLOHEXIL INDOL, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THE USE OF THE SAME FOR THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF DEPRESSION
UY30641A1 (en) DERIVATIVES OF 2- [1H-PIRAZOL-5-IL] AND 2- [2H-PIRAZOL-3-IL] HAVE [3,2-C] REPLACED PYRIDINS, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND APPLICATIONS
PA8531501A1 (en) METALOPROTEINASE INHIBITORS OF THE PYRIMIDIN-2,4,6-TRIONA TYPE
CY1113160T1 (en) ARYLURIA COMPOUNDS IN CONNECTION WITH OTHER CELLULAR OR CELLULAR MEDICINES FOR HUMAN CANCER TREATMENT
ECSP003610A (en) PYRIMIDINE-2,4,6 METALOPROTEIN INHIBITING TRIONES
GT200300177A (en) COMBINATION THERAPY FOR HYPERPROLIFERATIVE DISEASES
ATE437872T1 (en) PROTEIN KINASE INHIBITORS
AR029634A1 (en) USEFUL HETEROCICLIC DERIVATIVE COMPOUNDS AS ANTI-TARGET AGENTS, PHARMACEUTICAL COMPOSITION AND PROCESSING PROCEDURE
ECSP088966A (en) MUSCARINIC RECEIVER AGONISTS THAT ARE EFFECTIVE IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA
MX2007011695A (en) Substituted oxindole derivatives, medicaments containing the latter and use thereof.
UY29414A1 (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
NI200300045A (en) INHIBITORS OF TRIARILOXIARILOXIPIRIMIDIN-2,4,6-METALOPROTEINASE TRION.
ECSP055958A (en) 4-AMINOPIRIMIDINA-5-ONA
MX2007011698A (en) Substituted oxindole derivatives, medicaments containing the latter and use thereof.
UY26988A1 (en) NEW INDOLINONES REPLACED, ITS PREPARATION AND ITS USE AS MEDICINES.